Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

PD-161989: novel AMPA/GLYN receptor antagonist related to PNQX

Nov. 11, 1998

Unexpected adverse events encountered with bosentan in REACH-1 trial

Nov. 11, 1998

Synthelabo presents in vitro, ex vivo and in vivo data on new MAO-B inhibitor

Nov. 11, 1998

LY-300164 protects against kainate-induced neurotoxicity in vitro in a stereoselective manner

Nov. 11, 1998

Nonpeptide CRF1 antagonist developed at Parke-Davis modulates brain NE levels

Nov. 11, 1998

ATTRACT study establishes efficacy, safety of infliximab in RA patients

Nov. 11, 1998

Knoll develops potential new antipsychotic agent with advantages over available therapies

Nov. 10, 1998

LEF-553: a potent mu-opioid receptor agonist with peripheral analgesic effects

Nov. 10, 1998

Cevimeline improves symptoms of xerostomia in animal models, patients with Sjogren's syndrome

Nov. 10, 1998

NK1 antagonist L-732138 exhibits activity indicating efficacy in neuropathic pain

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...